LOGIN
AAOS 2025: 3-Month Infection Rates with Vancomycin and Povidone-Iodine Lavage in High-Risk THA
March 2025
AAOS 2025: 3-Month Infection Rates with Vancomycin and Povidone-Iodine Lavage in High-Risk THA
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Three-Month Wound Complication and Infection Rates After Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High-Risk Total Hip Arthroplasty: A Multicenter Randomized Control Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
Ninety-three patients with periprosthetic joint infection were randomized to receive either rapid 7-day exchange arthroplasty with intra-articular antibiotic irrigation (n=46) or standard two-stage exchange arthroplasty (n=47). The primary outcome of interest was treatment success at 12 months, defined as survival, absence of recurrent PJI, no re-operation on the index joint, completion of Stage 2...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.